{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:12:19Z","timestamp":1790233939364,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.maturitas.2006.07.009","type":"journal-article","created":{"date-parts":[[2006,9,2]],"date-time":"2006-09-02T07:22:32Z","timestamp":1157181752000},"page":"297-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism"],"prefix":"10.1016","volume":"55","author":[{"given":"Santiago","family":"Palacios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Foidart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea R.","family":"Genazzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2006.07.009_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0378-5122(95)00968-X","article-title":"The demography of menopause","volume":"23","author":"Hill","year":"1996","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2006.07.009_bib2","unstructured":"Consensus conference on hormone replacement therapy, October 2003. Final consensus statement. Royal College of Physicians of Edinburgh. Available at http:\/\/www.rcpe.ac.uk\/education\/standards\/consensus\/hrt_03.php [Accessed 6 July 2006]."},{"key":"10.1016\/j.maturitas.2006.07.009_bib3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(94)91640-3","article-title":"Is the timing of withdrawal bleeding a guide to endometrial safety during sequential oestrogen-progestagen replacement therapy? UK Continuous Combined HRT Study Investigators","volume":"344","author":"Sturdee","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2006.07.009_bib4","first-page":"732","article-title":"Use of the progestogen challenge test to reduce the risk of endometrial cancer","volume":"55","author":"Gambrell","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2006.07.009_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.maturitas.2005.02.007","article-title":"Guidelines for hormone treatment of women in the menopausal transition and beyond","volume":"51","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2006.07.009_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00117","article-title":"National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms","volume":"142","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2006.07.009_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.maturitas.2005.02.019","article-title":"Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004\/2005 position statements on peri- and postmenopausal hormone replacement therapy","volume":"51","author":"Skouby","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2006.07.009_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.gme.0000145876.76178.dc","article-title":"Recommendations for estrogen and progestogen use in peri- and postmenopausal women: October 2004 position statement of The North American Menopause Society","volume":"11","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2006.07.009_bib9","unstructured":"Royal College of Obstetricians and Gynaecologists. Menopause and Hormone Replacement\u2014study group recommendation. Consensus views arising from the 47th Study Group: Menopause and Hormone Replacement. Available at http:\/\/www.rcog.org.uk\/index.asp?PageID=310 [Accessed 6 July 2006]."},{"key":"10.1016\/j.maturitas.2006.07.009_bib10","first-page":"427","article-title":"The influence of menopause on blood pressure","volume":"3","author":"Staessen","year":"1989","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.maturitas.2006.07.009_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.jhh.1001095","article-title":"Hypertension in women","volume":"14","author":"Rosenthal","year":"2000","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.maturitas.2006.07.009_bib12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1161\/01.HYP.36.5.780","article-title":"Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative","volume":"36","author":"Wassertheil-Smoller","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.maturitas.2006.07.009_bib13","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.maturitas.2006.07.009_bib14","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.amjhyper.2005.10.006","article-title":"Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women","volume":"19","author":"Ichikawa","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.maturitas.2006.07.009_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/08037050510008788","article-title":"Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension","volume":"14","author":"Karalis","year":"2005","journal-title":"Blood Press"},{"key":"10.1016\/j.maturitas.2006.07.009_bib16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.maturitas.2006.07.009_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-135-4-200108210-00007","article-title":"Hormone replacement therapy and longitudinal changes in blood pressure in postmenopausal women","volume":"135","author":"Scuteri","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.maturitas.2006.07.009_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"273","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2006.07.009_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0039-128X(96)00007-4","article-title":"Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure","volume":"61","author":"Oelkers","year":"1996","journal-title":"Steroids"},{"key":"10.1016\/j.maturitas.2006.07.009_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3810\/pgm.2000.09.1.1204","article-title":"Weight gain during menopause. Is it inevitable or can it be prevented?","volume":"108","author":"Simkin-Silverman","year":"2000","journal-title":"Postgrad Med"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2006.07.009_bib21","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0378-5122(99)00073-0","article-title":"Weight gain and hormone replacement therapy: are women's fears justified?","volume":"34","author":"Van Seumeren","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2006.07.009_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/cmt.6.4.337.346","article-title":"Hormone therapy: the European women's perspective","volume":"6","author":"Strothmann","year":"2003","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2006.07.009_bib23","first-page":"491","article-title":"Hormone replacement therapy and blood pressure in hypertensive women","volume":"8","author":"Lip","year":"1994","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.maturitas.2006.07.009_bib24","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0002-9378(95)90018-7","article-title":"The influence of menopause and hormonal replacement therapy on body cell mass and body fat mass","volume":"172","author":"Aloia","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2006.07.009_bib25","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/humrep\/deg331","article-title":"Changes in body composition during post-menopausal hormone therapy: a 2 year prospective study","volume":"18","author":"Arabi","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.maturitas.2006.07.009_bib26","article-title":"Oestrogen and progestogen hormone replacement therapy for perimenopausal and postmenopausal women: weight and body fat distribution.","volume":"2","author":"Norman","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.maturitas.2006.07.009_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.GME.0000117062.54779.BD","article-title":"Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women","volume":"11","author":"Utian","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2006.07.009_bib28","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1067\/mob.2001.117669","article-title":"Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women","volume":"185","author":"Gambacciani","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.maturitas.2006.07.009_bib29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/oby.2001.81","article-title":"Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy","volume":"9","author":"Sorensen","year":"2001","journal-title":"Obes Res"},{"key":"10.1016\/j.maturitas.2006.07.009_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000010134","article-title":"Evaluation of the body composition and fat distribution in long-term users of hormone replacement therapy","volume":"48","author":"Perrone","year":"1999","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/j.maturitas.2006.07.009_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/jama.1996.03530250050026","article-title":"Long-term postmenopausal hormone use, obesity, and fat distribution in older women","volume":"275","author":"Kritz-Silverstein","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2006.07.009_bib32","first-page":"1549","article-title":"Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen\u2013Progestin Interventions Study Investigators","volume":"82","author":"Espeland","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2006.07.009_bib33","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.0001-6349.2004.00560.x","article-title":"Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45\u201364 years. The Norwegian Women and Cancer (NOWAC) study","volume":"83","author":"Bakken","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.maturitas.2006.07.009_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5122(02)00204-9","article-title":"The role of treatment intentions and concerns about side effects in women's decision to discontinue postmenopausal hormone therapy","volume":"43","author":"Reynolds","year":"2002","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2006.07.009_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1995.tb31386.x","article-title":"Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity","volume":"761","author":"Muhn","year":"1995","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.maturitas.2006.07.009_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2006.07.009_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progesterone","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.maturitas.2006.07.009_bib38","first-page":"459","article-title":"Progestogens with antimineralocorticoid activity","volume":"35","author":"Losert","year":"1985","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.maturitas.2006.07.009_bib39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0010-7824(92)90121-9","article-title":"Dihydrospirorenone (ZK30595): a novel synthetic progesterone\u2014characterization of binding to different receptor proteins","volume":"46","author":"Pollow","year":"1992","journal-title":"Contraception"},{"issue":"Suppl. 3","key":"10.1016\/j.maturitas.2006.07.009_bib40","first-page":"49","article-title":"Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties","volume":"6","author":"R\u00fcbig","year":"2003","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2006.07.009_bib41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13697130410001713698","article-title":"Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens","volume":"7","author":"Schurmann","year":"2004","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2006.07.009_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/13697130310001651535","article-title":"Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis","volume":"7","author":"Warming","year":"2004","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2006.07.009_bib43","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/01.gme.0000177318.24005.b1","article-title":"Long-term safety of drospirenone-estradiol for hormone therapy: a randomized, double-blind, multicenter trial","volume":"12","author":"Archer","year":"2005","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2006.07.009_bib44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mce.2003.10.030","article-title":"Drospirenone, a progesterone with antimineralocorticoid properties: a short review","volume":"217","author":"Oelkers","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.maturitas.2006.07.009_bib45","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.steroids.2003.08.008","article-title":"Conception and pharmacodynamic profile of drospirenone","volume":"68","author":"Elger","year":"2003","journal-title":"Steroids"},{"issue":"Suppl. 1","key":"10.1016\/j.maturitas.2006.07.009_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13697130500148875","article-title":"Pharmacology of estrogens and progestogens: influence of different routes of administration","volume":"8","author":"Kuhl","year":"2005","journal-title":"Climacteric"},{"key":"10.1016\/j.maturitas.2006.07.009_bib47","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00002512-200421130-00004","article-title":"New progestogens. A review of their effects in perimenopausal and postmenopausal women","volume":"21","author":"Sitruk-Ware","year":"2004","journal-title":"Drugs Aging"},{"key":"10.1016\/j.maturitas.2006.07.009_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1023\/A:1020072325818","article-title":"Pharmacokinetics and potency of progestins used for hormone replacement therapy and contraception","volume":"3","author":"Stanczyk","year":"2002","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.maturitas.2006.07.009_bib49","unstructured":"World Health Report 2002. Reducing risks, promoting healthy life. Geneva, Switzerland: World Health Organization; 2002. Available at http:\/\/www.who.int\/whr\/2002\/en\/index.html [Accessed 6 July 2006]."},{"key":"10.1016\/j.maturitas.2006.07.009_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.jhh.1000949","article-title":"Fifty years of Framingham Study contributions to understanding hypertension","volume":"14","author":"Kannel","year":"2000","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.maturitas.2006.07.009_bib51","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1161\/01.CIR.96.1.308","article-title":"Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study","volume":"96","author":"Franklin","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2006.07.009_bib52","unstructured":"WHO Statistical Information System (WHOSIS). World health statistics 2006. Available at http:\/\/www.who.int\/whosis\/whostat2006\/en\/index.html [Accessed 6 July 2006]."},{"key":"10.1016\/j.maturitas.2006.07.009_bib53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.maturitas.2004.01.010","article-title":"Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women","volume":"49","author":"Mueck","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2006.07.009_bib54","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0895-7061(02)02980-1","article-title":"Additive effect of drospirenone\/17-beta-estradiol in hypertensive postmenopausal women receiving enalapril","volume":"15","author":"Preston","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.maturitas.2006.07.009_bib55","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.amjhyper.2004.12.003","article-title":"Effects of drospirenone\/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women","volume":"18","author":"Preston","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.maturitas.2006.07.009_bib56","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1161\/CIRCULATIONAHA.104.501502","article-title":"Antihypertensive effects of drospirenone with 17\u03b2-estradiol, a novel hormone treatment in postmenopausal women with stage I hypertension","volume":"112","author":"White","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.maturitas.2006.07.009_bib57","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0895-7061(94)00250-F","article-title":"Lack of placebo effect on ambulatory blood pressure","volume":"8","author":"Mancia","year":"1995","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.maturitas.2006.07.009_bib58","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(01)06411-X","article-title":"Cardiovascular protection and blood pressure reduction: a meta-analysis","volume":"358","author":"Staessen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2006.07.009_bib59","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1097\/00004872-199612002-00009","article-title":"Blood pressure and the prevention of stroke","volume":"14","author":"MacMahon","year":"1996","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.maturitas.2006.07.009_bib60","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","article-title":"Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials","volume":"356","author":"Neal","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2006.07.009_bib61","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2006.07.009_bib62","first-page":"1816","article-title":"Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism","volume":"80","author":"Oelkers","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.maturitas.2006.07.009_bib63","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13625180008500387","article-title":"A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel","volume":"5","author":"Foidart","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.maturitas.2006.07.009_bib64","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13625180008500375","article-title":"Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone","volume":"5","author":"Huber","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512206002829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512206002829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T08:41:54Z","timestamp":1759912914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512206002829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0378512206002829"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2006.07.009","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2006.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}